Tom Ksiazek, former head of the CDC Special Pathogens Unit and current director of the High Containment Labotatory Operations at the Galveston National Laboratory, has just returned from Sierra Leone after six weeks there as the top official for the CDC.

As the Ebola virus outbreak rages in West Africa, the world-renowned team of infectious disease experts at the University of Texas Medical Branch at Galveston is at the forefront of the battle against this deadly disease — with clinical research, outbreak response and vaccine development.


Thomas Ksiazek, director of high containment laboratory operations for the Galveston National Laboratory at the University of Texas Medical Branch, left for Sierra Leone on Aug. 11 to lead Ebola outbreak containment operations for the U.S. Centers for Disease Control and Prevention. Ksiazek was the head of the Special Pathogens unit at the CDC, leading outbreak response around the world since the mid-1970s.

Thomas Geisbert has been researching the Ebola virus for more than 25 years, including several years with Fort Detrick's U.S. Army Medical Research Institute of Infectious Disease, working with the world's most vicious viruses. He recently received a $26 million grant from the National Institutes of Health to work on vaccines for the Ebola and Marburg viruses. He has developed an Ebola treatment that has been proven effective in animal studies.

Dr. A . Scott Lea is the Infectious Diseases Clinic Director at UTMB and is in charge of institutional protocols for treating patients with dangerous infectious diseases such as Ebola. He is available to speak to the media about how well the U.S. is prepared to handle Ebola; hospital and medical treatment protocols for treating patients with Ebola; disease symptoms, incubation, progression and transmission.


World Class Research Centers

This expertise and research is made possible by the Galveston National Laboratory , the only fully operational Biosafety Level Four laboratory on an academic campus in the U.S.

The work is enhanced by the capabilities of the Sealy Center for Vaccine Development, one of the most comprehensive vaccine development centers in the world, whose researchers are investigating new ways to treat infectious diseases of every type, from new strains of influenza to emerging diseases from every corner of the globe.


News and Resources


Videos: Ebola and Related Topics